Cam Battley Steps Down From Aurora

Aurora Cannabis' Chief Corporate Officer, Cam Battley, steps down from the behemoth cannabis company to work on MedReleaf in Australia.

Aurora Cannabis Inc. (TSX: ACB), the Canadian company defining the future of cannabis worldwide, announces a change to the Executive Team. Cam Battley has stepped down as Chief Corporate Officer effective December 20, 2019.  

Mr. Battley joined Aurora in 2016, serving a number of senior roles critical to the success of the company in its early years before being named Chief Corporate Officer in 2018. Mr. Battley has been instrumental in Aurora's international growth, serving as a powerful advocate and corporate voice in support of global acceptance.

Cam Battley
Aurora Cannabis' Former CCO, Cam Battley

Mr. Battley has earned the reputation as a formidable leader and advocate in Canada and beyond. With a clear passion for cannabis advocacy, Aurora is grateful for his contributions to the company's growth and role as a global medical cannabis leader.  As the Canadian cannabis industry evolves, Aurora continues to enhance its executive team to be fit for the longevity of the industry in Canada and beyond.

Our roots run deep, and Cam has been an integral part of the development, growth and expansion of Aurora.  Terry Booth, CEO of Aurora

"We are grateful for Cam's leadership and passion over his many years with Aurora. I am sure Cam will be successful as he moves on to tackle Australia," Booth concluded.

Mr. Battley was appointed to MedReleaf Australia's Board in November of 2019. This appointment has been approved by Australia's Federal Office of Drug Control. MedReleaf Australia is a privately held medical cannabis company established in 2016, based in Brisbane, Queensland. MedReleaf Australia is fully licensed to cultivate, manufacture, import and sell medical cannabis. Aurora holds a 10% stake as well as 50% voting rights in MedReleaf Australia. Australia has seen dramatic growth in the medical cannabis space over the last 18 months from less than 500 patients in June of 2018 to over 24,000 as of November 2019.

To learn more about Aurora, visit their company HQ here.

Disclaimer: Past performance is not an indicator of future performance.

Get the Latest Marijuana News &
Content in your Inbox!

All your support helps The Green Fund keep writing content for all you
marijuana enthusiasts and potential pot stock investors

Louis O'Neill
Louis O'Neill

Louis is a writer based in Sydney with a focus on social and political issues. Having interviewed local politicians and entrepreneurs, Louis now focuses on cannabis culture, legislation & reform.

Leave a Reply

Your email address will not be published. Required fields are marked *